wedge
Biotrofix, Inc. founded by Dr. Seth P. Finklestein & Dr. JingMei Ren
Biotrofix, Inc. founded by Dr. Seth P. Finklestein & Dr. JingMei Ren BIOTROFIX - Premier Preclinical CRO - Stroke, Alzheimer's, ALS, TBI Research - Seth P. Finklestein, M.D., CEO Biotrofix, Inc. founded by Dr. Seth P. Finklestein & Dr. JingMei Ren Biotrofix - Premier Preclinical CRO Services & Animal Research - Seth P. Finklestein M.D., CEO
Biotrofix, Inc. founded by Dr. Seth P. Finklestein & Dr. JingMei Ren Biotrofix, Inc. founded by Dr. Seth P. Finklestein & Dr. JingMei Ren Biotrofix, Inc. founded by Dr. Seth P. Finklestein & Dr. JingMei Ren Biotrofix, Inc. founded by Dr. Seth P. Finklestein & Dr. JingMei Ren Biotrofix, Inc. founded by Dr. Seth P. Finklestein & Dr. JingMei Ren
 
Home
greybar
The Company
greybar
Preclinical Drug Development
greybar
Preclinical Research Services
PK/PD Studies
Acute Stroke
Stroke Recovery
Intracerebral Hemorrhage
Alzheimer's Disease
Amyotrophic Lateral Sclerosis
Traumatic Brain Injury
Spinal Cord Injury
Muscular Dystrophy
Myocardial Infarction
Peripheral Vascular Disease
Others
Will Travel Services
greybar
The Team
greybar
News from Biotrofix
greybar
Publications
greybar
Contact Us
greybar
Careers


Well-equipped CRO laboratory
  Highest-quality preclinical efficacy contract services for CNS, vascular and other diseases

Biotrofix, Inc.

Biotrofix's mission is to provide the highest-quality preclinical efficacy contract services for CNS, vascular and other diseases to our Clients, who include biotech and pharmaceutical companies, as well as academic investigators.

Special strengths include extensive experience and expertise in preclinical modeling of CNS and vascular diseases, as well as a thorough understanding of all aspects of the drug development pathway.

Biotrofix possesses special expertise in small animal surgery, drug delivery methods, and behavioral assessment methods.

The goal is to provide high-level technical proficiency to Clients, as well as expert assistance in the planning, analysis and interpretation of preclinical efficacy studies. We're open, collaborative, and flexible regarding Clients' needs.

Biotrofix, Inc. was founded by Dr. Seth P. Finklestein and Dr. JingMei Ren, who have over 25 and 15 years of experience, respectively, in this field, in both academic and industrial settings.

Biotrofix is located in well-equipped laboratories, with an AAALAC-accredited animal facility. Biotrofix performs its services on a strictly fee-for-service basis, and takes no intellectual property rights on the work it does for clients.

A comprehensive report is submitted to clients at the end of each study. Biotrofix currently provides contract services for several leading biotech and global pharmaceutical companies.

 

 
 
Home | The Company | Preclinical Research Services | The Team | News | Publications | Contact Us | Site Map
wedgeBiotrofix, Inc. 604 Webster Street, Needham, MA 02494 Tel: 781-786-8890 Fax: 781-465-6061


Biotrofix is a premier preclinical contract research organization specializing in animal models of CNS, cardiac and vascular disease. With years of experience, both academic, commercial, clients throughout the biotech and pharmaceutical industries, Biotrofix delivers industry-leading preclinical CRO services, including rodent models of acute stroke and stroke recovery, preclinical CRO services for Alzheimer's Disease, transgenic animal models for ALS, as well as CRO services for brain injury, preclinical CRO services for spinal cord injury and related cardiac drug discovery and development.